Latest News

FDA no longer needs to require animal tests before human drug trials

January 10, 2023 |

New medicines need not be tested in animals to receive U.S. Food and Drug Administration (FDA) approval, according to legislation signed by President Joe Biden in late December 2022. The change—long sought by animal welfare organizations—could signal a major shift away from animal use after more than 80 years of drug safety regulation.

Back to top

Expensive prescription drugs are a bargain

September 13, 2022 | The Wall Street Journal

This opinion piece describes aspects of the Inflation Reduction Act that may hamper pharmaceutical innovation: "The Inflation Reduction Act has eight provisions intended to reduce future drug prices. Some observers were surely pleased that Congress gave the Centers for Medicare and Medicaid Services new powers to negotiate with pharmaceutical companies. They shouldn’t have been. The Inflation Reduction Act won’t noticeably reduce inflation and it will do little or nothing to lower the cost of healthcare. Forcing drug companies to charge lower prices will likely lead to fewer new drugs."

Back to top

HHS announces establishment of new research agency under NIH

April 21, 2022 | Law Street Media

The Department of Health and Human Services officially transferred the Advanced Research Projects Agency for Health (ARPA-H) to the National Institutes of Health (NIH) Wednesday, according to the Federal Register. ARPA-H was officially created as an agency in Public Law 117-103, as a part the Consolidated Appropriations Act of 2022. This transfer includes delegating the authority to the Director of NIH to administer, fund, and appoint personnel to the new agency.

Back to top

Monash University tops the world in pharmacy and pharmacology

April 7, 2022 | The Age

Monash University has been ranked Number 1 in pharmacy and pharmacology, beating Oxford, Harvard and Cambridge. Monash University was recognised for a range of factors, including developing Australia’s first mRNA COVID-19 vaccine and its work on developing life-saving treatment for women who die during childbirth in developing countries.

Back to top

JPMorgan's big healthcare conference goes virtual on Omicron concerns

December 15, 2021 | The Wall Street Journal

JPMorgan Chase & Co. is moving its big annual healthcare conference in San Francisco to a virtual setting, telling participants the spreading Omicron variant of Covid-19 had made the in-person gathering too risky. The bank’s annual gathering is one of the biggest events for global healthcare professionals and CEOs, and it is often full of deal making. This year’s event, scheduled for the middle of January, will be the 40th version. The move comes after several biotechnology companies pulled out of planned in-person appearances, which were first reported on Tuesday by Stat News.

Back to top